Category · FY2027
C22 Malignant neoplasm of liver and intrahepatic bile ducts
- Header · not billable
C22 is not billable. The category heads 8 billable codes in FY2027: the 8 codes directly below it.
Index → code
Where it sits
- Chapter 2 Neoplasms (C00-D49)
- C15-C26 Malignant neoplasms of digestive organs (C15-C26)
- C22 Malignant neoplasm of liver and intrahepatic bile ducts
- Billable codes
- 8
- Subdivisions
- 8
- CC / MCC codes
- 8 / 0
- HCC V28 codes
- 8
- New FY2027
- 0
- Index entries
- 37
Codes in C22
- C22.0Liver cell carcinomaBillableCC20
Inclusion terms 2
Inclusion terms
- Hepatocellular carcinoma
- Hepatoma
- C22.1Intrahepatic bile duct carcinomaBillableCC20
Inclusion terms 1, Excludes1 1
Inclusion terms
- Cholangiocarcinoma
Excludes1
- malignant neoplasm of hepatic duct (C24.0) C24.0
- C22.2HepatoblastomaBillableCC20
- C22.3Angiosarcoma of liverBillableCC20
Inclusion terms 1
Inclusion terms
- Kupffer cell sarcoma
- C22.4Other sarcomas of liverBillableCC20
- C22.7Other specified carcinomas of liverBillableCC20
- C22.8Malignant neoplasm of liver, primary, unspecified as to typeBillableCC20
- C22.9Malignant neoplasm of liver, not specified as primary or secondaryBillableCC20
CC/MCC: as a secondary diagnosis, unless the principal diagnosis is on the code’s PDX exclusion list (MS-DRG v44 Appendix C; list on the code card).
Instructions
At C22
Excludes1
Notes that also apply
Block C15-C26 instructions (Excludes1 1, Excludes2 1): printed on the block page.
Chapter 2 instructions (Notes 8): printed on the chapter 2 page.
Index entries
- Cholangiohepatoma → C22.0
- Hepatocarcinoma → C22.0
- Hepatocholangiocarcinoma → C22.0
- Hepatoma (malignant) → C22.0
- Hepatoblastoma → C22.2
- Kupffer cell sarcoma → C22.3
- Cancer›hepatocellular → C22.0
- Carcinoma (malignant)›hepatic cell → C22.0
- Carcinoma (malignant)›hepatocellular → C22.0
- Carcinoma (malignant)›hepatocholangiolitic → C22.0
- Carcinoma (malignant)›liver cell → C22.0
- Cholangiocarcinoma›with hepatocellular carcinoma, combined → C22.0
- Embryoma›liver → C22.0
- Hepatoma (malignant)›embryonal → C22.0
- Adenocarcinoma›bile duct type → C22.1
- Cancer›bile duct type liver → C22.1
- Cholangiocarcinoma›liver → C22.1
- Cholangiocarcinoma›unspecified site → C22.1
- Cystadenocarcinoma›bile duct → C22.1
- Angiosarcoma›liver → C22.3
- Sarcoma (of)›Kupffer cell → C22.3
- Sarcoma (of)›liver NEC → C22.4
- Carcinoma (malignant)›liver NEC → C22.7
- Teratocarcinoma›liver → C22.7
- Teratoma (solid)›liver → C22.7
- Carcinoma (malignant)›bile duct›with hepatocellular, mixed → C22.0
- Carcinoma (malignant)›hepatocellular›with bile duct, mixed → C22.0
- Carcinoma (malignant)›hepatocellular›fibrolamellar → C22.0
- Embryoma›malignant›liver → C22.0
- Adenocarcinoma›bile duct type›liver → C22.1
- Adenocarcinoma›bile duct type›unspecified site → C22.1
- Carcinoma (malignant)›bile duct›liver → C22.1
- Carcinoma (malignant)›bile duct›unspecified site → C22.1
- Tumor›mesodermal, mixed›liver → C22.4
- Carcinoma (malignant)›embryonal›liver → C22.7
- Teratoma (solid)›embryonal›liver → C22.7
- Tumor›embryonal (mixed)›liver → C22.7
NCHS Alphabetic Index. Index first, then the Tabular List.